BIS icon

ProShares UltraShort NASDAQ Biotechnology

6 hedge funds and large institutions have $550K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
1
Calls
$4K
Puts
$23K
Net Calls
-$19K
Net Calls Change
+$4K
Name Market Value Shares Shares
Change
Shares
Change %
IMC Chicago
1
IMC Chicago
Illinois
$271K 15,001 +15,001 New
Citadel Advisors
2
Citadel Advisors
Florida
$181K 10,025 -12,339 -55%
TRCT
3
Tower Research Capital (TRC)
New York
$85.3K 4,721 -5,404 -53%
Morgan Stanley
4
Morgan Stanley
New York
$5.85K 324 +203 +168%
UBS Group
5
UBS Group
Switzerland
$4.93K 273 +267 +4,450%
Citigroup
6
Citigroup
New York
$1.54K 85
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
-11,572 Closed
CFGS
8
Concourse Financial Group Securities
Alabama